CD34+ cells devoid of detectable mature and immature T and B lymphocytes, expressing the CD2, CD10, and CD20 antigens, were isolated from marrows of three pairs of sexmismatched, mixed lymphocyte culture (MLC) nonreactive, sibling baboons. Reciprocal transplants were performed between members of each pair, using the sex chromosomes, identified by standard cytogenetic techniques, as markers of the transplanted cells. Five animals from these three pairs were transplanted with 0.6 t o 2.1 x 10b/kg of isolated cryopreserved and/or fresh isolated cells that were greater than 95% to 97% CD34+. Before transplantation, animals were treated with either single (920 or 1,020 cGy] or split (700 cGy x 2) dose total body irradiation. All animals engrafted with donor cells, as demonstrated by cytogenetic analysis of bone marrow metaphase cells 4 weeks after transplantation, with days t o white blood cell count (WBC) >500 being 19 2 2, t o WBC > 1.000 23 f 2, t o absolute neutrophil count >500 24 f 3, and t o platelets >20,000 30 f 7. Three animals died of infectious-related complications at 34,42, and 109 days after HE CHARACTERIZATION and isolation of human
T hematopoietic stem cells (HSCs) has been of interest both to further OUT understanding of the biology of these cells as well as for potential clinical applications. In mice, highly enriched populations of HSCs have been isolated based on physical, antigenic, and metabolic properties as demonstrated by their contributions of progeny to multiple myeloid and lymphoid lineages in vivo after transplantation, and their ability to sustain hematopoiesis throughout at least one animal's 1ife-s~an.l.~ In humans, evidence also suggests that pluripotent HSCs e x i~t .~,~
The development of monoclonal antibodies (MoAbs) to antigenic determinants on human hematopoietic cells has allowed definition and isolation of subsets of marrow that contain precursor cells, thus enabling informative studies of the biologic function of these cells in vitro and in vivo. Antibodies to the CD34 antigen7-" have been of interest because they react with a minor subset of cells in human marrow and peripheral blood that contains virtually all detectable in vitro hematopoietic colony-forming cells (CFC).7,9J0 This population contains precursors of CFC that can be detected in long-term marrow cultures10 and cells that coexpress antigens known to be present on immature T and B lymphocyte^.^^-^^ The CD34+ population devoid of progenitor cells and cells expressing lymphoid antigens, termed lineage negative (lin-), have been presumed to contain candidate stem ~e l l s .~~J~ However, there is no definitive evidence that cells within the CD34+ population have the properties of stem cells in vivo.
We have shown that the CD34 antigen is expressed by a minor subset of hematopoietic cells in the marrows of nonhuman primates, including baboons and macaque species, that includes virtually all unipotent and multipotent CFC, and that enriched populations of autologous marrow CD34+ cells can engraft lethally irradiated baboons." Based on these findings, it was shown that enriched transplantation with evidence of host and donor cells (mixed chimerism) in marrow. Two animals remain alive and healthy more than 545 and 455 days after transplantation with stable mixed chimerism in marrow and blood. For these two animals, cytogenetic analysis of granulocyte/ macrophage and erythroid colonies derived from marrow precursors between weeks 25 and 42 posttransplant showed evidence of mixed chimerism. Cytogenetic studies of CD2+ T cells and CD20+ B cells isolated from blood of these two animals between weeks 21 and 51 posttransplant showed the presence of mixed chimerism in both lymphocyte populations. Thus, isolated allogeneic CD34+ marrow cells devoid of detectable mature and immature T and B lymphocytes can engraft and reconstitute stable long-term myelopoiesis and lymphopoiesis in lethally irradiated baboons. These results are consistent with the hypothesis that CD34+ marrow cells contain pluripotent hematopoietic stem cells capable of fully reconstituting lymphohematopoiesis in the transplanted host. o 1992 by The American Society of Hematology.
autologous CD34+ marrow cells could engraft and establish hematopoiesis in humans treated with high-dose chemoradiotherapy.ls These studies did not distinguish between donor and residual host cells; therefore, it could not be determined if the observed initial hematopoietic recovery was due to the infused CD34+ marrow cells and whether later hematopoiesis after initial engraftment was due to residual radiation and chemotherapy-resistant host cells. In the studies presented here, we transplanted CD34+ marrow cells depleted of mature T and B lymphocytes, as well as immature ones that express CD34 and T-and B-associated antigens. We then determined if these putative purified stem cells were capable of long-term reconstitution of both the myeloid and lymphoid compartments of irradiated 1694 ANDREWS ET AL mixed lymphocyte culture (MLC) nonreactive, sex-mismatched, sibling baboons.
MATERIALS AND METHODS

Animals.
Healthy juvenile baboons (Papio cynocephalus) were housed at the University of Washington Regional Primate Research Center, under American Association for Accreditation of Laboratory Animal Care approved conditions. Studies were conducted under Institutional Review Board and Animal Care and Use Committee approved protocols. All animals were provided with water, biscuits, and fruit ad libitum throughout the study. Marrow was aspirated from both femora and humeri to isolate cells for transplantation. Indwelling central venous catheters were inserted via the femoral vein for use with a tether system previously described.19 All animals were treated with intravenous broad spectrum antibiotics (piperacillin 100 mgikg three times daily [TID] and gentamicin 1.7 mgikg TID) until they achieved a granulocyte count of > 500, were transfusion independent, and their catheters were removed. All animals were administered cyclosporine A (6 mglkgid IV or IM) starting at day -1, the day before TBI. Cyclosporine administration was stopped for A89163 and A89164 12 and 15 months posttransplant, respectively. All blood samples were drawn through the line while it was in place. All procedures, including bone marrow (BM) biopsies, BM aspirates, and blood drawing without a line, were performed after anesthesia with a combination of ketamine-HCI (Aveco, Fort Dodge, IA) and xylazine (Haver, Shawnee, KS). Marrow biopsies were fixed in B-5. Complete blood counts (CBC) were performed daily until animals were transfusion independent, after which time they were performed as indicated. Immediately before transplantation all animals were administered single-dose (920 or 1,020 cGy) or split-dose (700 cGy x 2, doses 24 hours apart) total body irradiation (TBI) from two opposing %obalt sources at a rate of 7 cGyimin. Animals were transfused with irradiated (2,000 to 3,000 cGy) fresh whole blood for treatment of thrombocytopenia and anemia, as previously described."
Unfractionated and isolated marrow cells were cultured in a double-layer agar culture system, as previously described.20 Briefly, isolated cells were cultured in a medium supplemented with 25% fetal bovine serum (FBS; Hyclone, Logan, UT), 0.1% bovine serum albumin (BSA; fraction V; Sigma, St Louis, MO), 0.3% (wtivol) agar (Difco, Detroit, MI), overlaid on medium with 0.5% agar (wtivol) containing recombinant human growth factors: stem cell factor (SCF; 100 ngimL Amgen, Thousand Oaks, CA), interleukin-lp (IL-1p; 20 ng/mL; Immunex, Seattle, WA), IL-3 (50 ng/mL; Amgen), granulocyte-macrophage colony-stimulating factor (GM-CSF; 20 ng/mL; Amgen), and erythropoietin (Epo; 2 UlmL; Amgen) (growth factors were kindly provided by Dr K. Zsebo [Amgen] and Dr D. Williams [Immune~]). Cells were plated at 2,000 to 50,000 cells per dish depending on the expected enrichment of the sample. Cultures were incubated at 37°C in 5% 0 2 , 5% CO2, humidified incubator. All cultures were performed in triplicate unless otherwise indicated. At day 14 of culture, colonies were enumerated using an inverted microscope. Data on CFC is reported as the mean ? 1 SD per 5 x lo4 cells in culture. Colony-forming unit granulocytemacrophage (CFU-GM) and burst-forming unit-erythroid (BFU-E) colonies picked for cytogenetic analysis were grown, as described above, at cell densities that allowed growth of only a few colonies (3 to 20) per plate. This allowed colonies to be picked with minimal contamination from other proliferating cells in the cultures. At day 14 of culture, colonies of a desired type were identified using a dissecting microscope, picked, pooled, washed to remove the semisolid medium, and prepared for chromosome analysis.
CFC assays.
MoAbs. MoAb 5B12 reacts with a 40-to 45-Kd membrane protein expressed by maturing granulocytic cells in baboon marrow but not by baboon marrow CFC (Bartelmez S.H. and Andrews R.G., unpublished observations). Briefly, Balbic mice were immunized intraperitoneally (IP) with 10 x IOh density selected ( < 1.085 specific gravity) baboon marrow cells plus incomplete Freund's adjuvant (1:l). Three subsequent IP immunizations were administered weekly with the same dose of selected baboon marrow cells in phosphate-buffered saline (PBS). One week after the last IP immunization, animals were boosted intravenously with the same number of selected baboon marrow cells in PBS, and 4 days later the spleens were harvested for fusion. Spleen cells from immunized mice were fused with cells from the SP2iO myeloma cell line, as described.In Hybrids secreting mouse Ig were screened by flow cytometry for reactivity with baboon marrow cells. Hybrids with the desired reactivity were formally cloned and then grown as ascites tumors in pristane primed Balbic micel0 to obtain ascites fluids containing high titers ( > 1:10,000) of the desired antibody. Antibodies in ascites fluids were used at final dilution of 1:1,000 unless otherwise specified.
MoAbs 9.6 (CD2) and 51. Depletion of mature T and B lymphocytes and granuloqtic and monocytic cells by immunoadsorption of magnetic beads. Marrow buffy coat cells were labeled with MoAbs 9.6 (CD2), 1F5 (CD20), S8S (CDlO), (328.5 (CDw40), and 5B12 (IgG2a) for 30 minutes at 4"C, washed, and then mixed with anti-IgG-conjugated magnetic beads (Dynal, Oslo, Norway) at a ratio of 5 beads per cell. The suspension was mixed gently and then pelleted at 50g for 5 minutes at 4°C. The pellet was then gently resuspended and cells adherent to the magnetic particle as well as unbound magnetic beads were removed from suspension by use of a magnet, as described.I5 The unbound cells remaining in suspension were transferred to separate tubes and washed twice.
Positive selection of CD34 + marrow cells by immunoadsorption. Marrow buffy coat cells were labeled with the IgM MoAb 12-8 (CD34) at 4°C for 30 minutes, washed, and then labeled with biotin-conjugated goat antimouse IgM-specific antisera (Tago, Burlingame, CA) for 30 minutes at 4"C, and then washed. The cells were then applied to an affinity column containing Biogel conjugated to avidin, as previously described." The cells adherent to the affinity column were eluted by mechanical agitation of the gel at the same time that buffer was rapidly run through the column. The collected adherent cells were washed twice, and then used for further isolation of cells by two-color cell sorting.
Immunofluorescent staining and isolation of CD34+ cells by cell sorting. Cells remaining after depletion of T and B lymphocytes and granulocytic and monocytic cells, or enriched by immunoadsorption, were simultaneously labeled with the IgM MoAb 12-8 (CD34) and the IgG MoAbs used for depletion (9.6, S8S, 1F5, G28.5, and 5B12). The cells were then stained with phycoerythrin conjugated anti-IgM-specific antisera (Cal Biochem, La Jolla, CA, or Biomeda, Foster City, CA) and fluoroscein isothiocyanate (F1TC)-conjugated IgG-specific antisera (Kirkegaarde and Perry, Gaithersberg, MD).I5 As controls, unfractionated marrow buffy coat cells were labeled with the IgM antibody H12C12 (antimouse Thy 1.2) and the IgG antibodies 31.A and 1A14 (anti-Thy 1.1) and then stained with the anti-IgM-specific and the anti-IgG-specific antisera.I5 The cells stained with 12-8 (fluorescence intensity greater than 99% of cells stained with the IgM control antibody) and not
CD34+ CELLS RECONSTITUTE LYMPHOHEMATOPOIESIS 1695
detectably stained with the antibodies used for negative selection (fluorescence intensity less than the brightest 10% of cells stained with the IgG-negative control antibodies) were then isolated by two-color fluorescence activated cell sorting using a modified FACS-I1 (Becton Dickinson, Mountain View, CA). CD34+ cells were isolated and cryopreservedZ1 at three separate times for each of the animals A89163, A89164, and A89161 (donor for A89162), and at four separate times for each of the animals A89159 and A89160. At the time of transplantation, the cryopreserved (> 90% viable by trypan blue dye exclusion) and, in some cases, freshly isolated cells were infused into the recipient.
Phenotypic analysis of peripheral blood cells from transplanted baboons. Peripheral blood buffy coat cells were labeled with IgG antibodies 9.6 (CD2), G17.2 (CD4), 51.1 (CD8), and 1F5 (CD20), after which they were stained with the FITC-conjugated IgGspecific antisera, as described above. As controls, cells were labeled with 31.A. Cells were analyzed and sorted using the modified FACS-11. CD2+ and CD20+ cells isolated by sorting had fluorescent staining that was greater than 99% of the cells stained with the negative control antibodies. Analysis of sorted cells showed that they were greater than 95% of the desired phenotype.
MLC reactivity of peripheral blood cells from baboons was performed as previously described.22 MLC typing was used to define sibling baboons that were major histocompatibility complex (MHC) identical as there are presently no serologic or molecular reagents that can reliably define baboons that are identical at the major histocompatibility loci. Cells from each baboon were tested for reactivity in MLC with cells from each of its sibs, cells pooled from unrelated baboons, and autologous controls. were calculated. We initially tested siblings from the same Dam from a troop of baboons with a single known dominant male, but with other mature males in the troop. We tested 23 sibships containing two to four siblings, a total of 66 animals, and found no pairs of MLC nonreactive siblings.
We then tested 20 sibships of two or more animals derived from the pedigreed breeding programs at Southwest Foundation for Biomedical Research (San Antonio, TX) containing 59 animals, with a total of 47 possible pairings. In this group of animals, we identified nine sibling pairs (19%) that were MLC nonreactive. Three of these pairs were both males, two pairs were both female, and four pairs (8% to 9%) were male-female, or sex-mismatched. Of these, in three of the pairs both animals were suitable in size for purposes of the transplantation studies.
Chromosomes from unfractionated BM were prepared from direct and 24-hour unstimulated cultures. Chromosomes from unfractionated peripheral blood and sorted CD2+ cells were prepared from 96-hour cultures stimulated with phytohemagglutinin (PHA) and IL-2.23 Sorted CD20 cells from blood were cultured for 48 to 72 hours with dead Staphylococcus A Cowan strain (SAC) and IL-2, with or without 5% B-cell growth factor (BCGF) preparation (Cytokine Research, Buffalo, NY).
CFU-GM and BFU-E colonies were pooled, washed, and cultured for 1 hour in medium with colcemid. Metaphase chromosomes for all cultures were harvested following standard techniques of colcemid treatment (0.04 pgimL), hypotonic treatment (0.075 mol/L KCl), and methanol acetic acid fixation. Air-dried slides were prepared and chromosomes were G-banded with trypsin and Wrights stain.u Cells from male (42,XY) and female (42,XX) baboons were distinguished by metaphase chromosome analysis consisting of chromosome count and identification of sex chromo-MLC testing.
Cytogenetic analysis.
some complement. The cytogenetic analysis was performed without the reader knowing the sex of the animal or the treatment that the animal had received.
RESULTS
Isolation of CD34+ mamow cells depleted of mature and immature T and B lymphocytes. CD34+ cells depleted of mature and immature T and B lymphocytes were isolated from the marrows of MLC nonreactive, sex-mismatched, sibling baboons (Table 1) . Marrow b u m coat cells were depleted of CD2, CD10, CD20, and CDw40 antigenexpressing cells, and granulocytic cells binding the 5B12 antibody by immunoadsorption to magnetic beads. The cells remaining after depletion (Fig 1) still had detectable levels of antigen-bearing cells. Cells expressing the CD34 antigen, detected by labeling with antibody 12-8, but not expressing the antigens used for depletion, were isolated by two-color fluorescence activated cell sorting (FACS) (Fig  1) . In one experiment, some of the transplanted cells were separated by first enriching for CD34+ cells by immunoadsorption and then using two-color FACS to isolate CD34+ cells but exclude those remaining cells that expressed the CD2, CD10, CD20, CDw40, and 5B12 antigens that were not depleted by immunoadsorption. Analysis of isolated cells immediately before cryopreservation showed that in all cases the sorted cells were 295% CD34+ and had no detectable cells stained with the antibodies to the T, B, and granulocyte antigens (Fig 1) . Cultures of these cells performed before cryopreservation and at the time of transplantation confirmed enrichment of colony-forming progenitors ( Table 2) .
Engrajlment of isolated CD34+ allogeneic marrow cells in sibling baboons and clinical course. Five of the six animals in the three sibling pairs were transplanted with 0.6 to 2.1 x 106/kg of cryopreserved marrow cells that were 295% CD34+ and contained no detectable cells labeled with antibodies against the CD2, CD10, CD20, and CDw40 antigens. All five animals engrafted, with evidence of increasing total white blood cell (WBC) and neutrophil (ANC) counts, and evidence of trilineage engraftment on Log Fluorescence Intensity- marrow biopsy ( Table 3) . The mean times to recovery of WBC counts, ANC, and platelet counts were 7 to 12 days longer than the mean times observed for baboons transplanted with fresh, noncryopreserved autologous whole marrow (Table 2) and fresh, noncryopreserved, autologous, enriched CD34+ marrow cells.17 Cytogenetics on spontaneously dividing marrow cells 4 weeks after transplant showed that 50% to 100% of these cells were donor derived (mean f SD = 84% f 21%) ( Table 4) .
The three animals administered the highest doses of TBI (1,400 and 1,020 cGy), as preparation for the transplant, died of infection-related problems. Animal A89159 died 42 days posttransplant of documented Babesiosis with overwhelming hemolytic anemia and renal failure. At the time of death, a marrow biopsy showed trilineage engraftment with 50% of normal cellularity, and cytogenetic analysis showed mixed chimerism (100% of 21 metaphases were donor). Animal A89160 died at day 34 posttransplant of sepsis with perforated ulcers in his stomach and small intestine. At the time of death, a marrow biopsy showed 70% of normal cellularity with trilineage engraftment, and cytogenetic analysis showed mixed chimerism (80% of 20 metaphases were donor). Animal A89162 died 109 days posttransplant of sepsis and chronic diarrhea of undetermined etiology, with a normal cellular marrow and trilineage engraftment. This animal had evidence for mixed chimerism in both blood and marrow at the time of death (Table 4) .
Two animals, A89163 and A89164, remain alive and healthy, with stable hematopoietic reconstitution (Fig 2) , now more than 545 and 455 days posttransplantation, respectively. Both animals have evidence of stable mixed chimerism in marrow and peripheral blood ( Table 4) .
Analysis of chimerism in marrow of transplanted baboons: Contributions to myeloid and erythroid compartments. Four weeks after transplantation, all animals showed evidence of donor cells in their marrow by cytogenetic analysis of unfractionated and unstimulated marrow cells. The three animals that died showed donor cells in their marrow at the time of death. The two surviving animals showed stable mixed chimerism in studies of unfractionated marrow performed every 3 to 6 weeks (data not shown).
The metaphases derived from spontaneously dividing cells in unfractionated marrow presumably arise from hematopoietic cells, but the cell lineage was not determined. Therefore, marrow-derived CFU-GM and BFU-E were picked and pooled for cytogenetic analysis. Metaphases of donor type were detected in pooled colonies from each animal, suggesting that CFC and their progeny are derived from the transplanted CD34+ cells in both animals ( Table  5 ). The frequency of donor type metaphases was similar for both the pooled colonies and the spontaneously dividing marrow cells. Thus far, the mixed chimerism has remained stable in both animals for more than 545 and 455 days.
Analysis of chimerism in peripheral blood of transplanted baboons: Contributions to T-and B-cell compartments. The three animals (A89164, A89163, and A89162) that survived beyond day 60 posttransplant had evidence for mixed chimerism in blood by cytogenetic analysis of PHAstimulated blood cells ( Table 4) . Cultures of PHA- stimulated peripheral blood cells from the two animals that died early (A89159 and A89160) were either not performed or showed no metaphase cells for analysis. Because donor-derived cells were identified in cultures of unseparated blood cells stimulated with PHA and IL-2 were presumably T cells, we directly tested isolated peripheral blood T cells to determine their origin. Cells expressing the CD2, CD4, and CD8 antigens were present in the blood of both animals at frequencies that were similar to untransplanted baboons (Table 6 ). CD2+ cells isolated from the blood of both animals showed presence of donor cells by cytogenetics ( Table 7 ) .
We then asked if B cells in blood contained donorderived cells. CD20+ cells were detected in the circulation of both animals at frequencies similar to that of untransplanted animals (Table 6 ). Unfractionated whole blood cells from animal A89164, 51 weeks posttransplant, cultured with SAC, IL-2, and BCGF, showed 6 of 20 metaphases to be donor. CD20+ blood cells isolated from the same blood sample from this animal and cultured in the same way did not yield evaluable metaphases. CD20+ cells from the blood of A89163, 32 weeks posttransplant, cultured with SAC and IL-2 showed 7 of 8 evaluable metaphases to be donor. These results provide evidence for donor cells contributing to T-and B-lymphoid lineages in the blood of baboons transplanted with CD34+, T-and B-lymphocyte-depleted, marrow cells.
DISCUSSION
The identification of HSCs has been a major goal of many investigators interested in the biology of hematopoiesis.
Studies in the mouse have defined antigenic characteristics of a minor population of hematopoietic cells that have properties of pluripotent stem
In humans, transplantation studies in which normal and leukemic lymphocytic and myelocytic cells have been depleted from marrow support the hypothesis that stem cells may not express many lineage-and stage-restricted antigen^.^^"^ The identification of the CD34 antigen, and the demonstration of its expression by virtually all unilineage, mixed-lineage, blast-cell, and high proliferative potential-CFC (HPP-CFC)7$9-tt.31 as well as by precursors for these CFC in long-term culturelo suggested that this antigen may be expressed by cells with stem cell activity in vivo. The finding that the CD34 antigen was also expressed by hematopoietic cells with the phenotypic characteristics of immature T and Data are number of donor metaphases/number of metaphases examined. Karyotyping was performed o n unstimulated and unfractionated marrow cells, and o n unfractionated peripheral blood cells CUItured with PHA and IL-2.23
Abbreviations: NM, no metaphases found in cultures performed at weeks 1, 4, and 6 posttransplant; NA, the animal was not alive at that time point; ND, not done. B lymphocytes further suggested that stem cells capable of generating both myelopoietic and lymphopoietic progeny might express the CD34 antigen.12-14 In nonhuman primates, the CD34 antigen is conserved in its expression on unilineage and mixed lineage hematopoietic CFC," as are the CD2, CD10, CD20, and CDw40 antigens on lymphocyte^.^^-^^ Previous studies have shown that enriched populations of autologous CD34+ marrow cells can engraft and rescue lethally irradiated baboons, while marrow cells depleted of CD34+ cells could not.I7 These studies lacked a genetic marker, making it impossible to determine if the transplanted CD34+ cells were responsible for long-term maintenance of hematopoiesis in vivo, or whether they simply provided hematopoietic progeny to support the animal until endogenous radiation-resistant stem cells could repopulate hematopoietic tissues. Data are number of donor metaphases/number of metaphases examined. Colonies were picked and pooled for cytogenetic analysis as described (see Materials and Methods). Results from whole marrow represent studies performed using unstimulated and unfractionated marrow cells.
Abbreviation: NM, no metaphasesfound. *Cultures of unfractionated and unstimulated whole marrow.
In the present studies, we transplanted MHC-matched siblings with allogeneic CD34+ marrow cells that were devoid of CD2+ T and CD10+, CD20+, and CDw40+ B cells detectable by flow cytometry. The potential for levels of contaminating lymphocytes, which were not detected by flow cytometry, in the transplanted populations cannot be excluded, and we did not assay for the expression of other antigens that are expressed by immature lymphocyte precursors. However, these CD34+ cells reconstituted hematopoiesis early after transplantation, and also reconstituted stable long-term hematopoiesis in vivo. Most importantly, they reconstituted both myelopoiesis and lymphopoiesis, with evidence that mature T lymphocytes expressing the CD2 antigen and mature B lymphocytes expressing the CD20 antigen were derived from these transplanted cells. Chromosome analysis of metaphase cells from unfractionated, unstimulated marrow cells from animals posttransplant showed that donor-derived cells with replicative potential persisted over time. By studying pools of CFU-GM and BFU-E colonies separately it was shown definitively that myeloid progenitor cells in the marrow of transplanted animals were donor derived. The contribution of donor cells to lymphopoiesis posttransplant was suggested by cytogenetic analysis of PHA-stimulated peripheral blood cells. By studying CD2+ and CD20+ cells isolated from the blood of animals posttransplant, it was possible to directly show the presence of donor-derived cells.
The use of conventional cytogenetic methods for sex chromosome complement determination as the genetic marker for analysis of chimerism in these animals limits the evaluation to dividing cells. In situ hybridization using chromosome-specific DNA probes permits the evaluation of interphase cells, and this approach has been used to determine the origin of marrow cells in human BM transp l a n t~.~~ Repetitive sequence probes specific for the human X and Y chromosomes are not reliable for in situ hybridization to baboon sex chromosomes. This is not surprising considering that concerted evolution is a feature of cr satellite DNA.44 DNA probes for baboon X and Y chromosome-specific sequences will be required for interphase cell analysis. A male specific DNA sequence in baboons and macaques has recently been identified, and can be detected by polymerase chain reaction (PCR), and preliminary studies of unseparated, CD20+, and CD2+ blood cells from A89163 (a female transplanted with CD34+ cells from a male), at more than 300 days posttransplant, have confirmed the chimeric nature of hematopoiesis (M. Reitsma and M. Pallavicini, personal communication). Further studies using this new approach should yield additional information about chimerism in other lineages and cell types thought to be derived from HSCs.
Although the irradiation regimens used to treat animals before transplantation in our study were not completely myeloablative, all animals have been mixed chimeras in their hematopoietic tissues. The surviving baboons will continue to be observed to determine the longevity of chimerism resulting from the transplantation of CD34+ lymphocyte-depleted allogeneic marrow cells.
Transplantation of enriched allogeneic CD34+ marrow cells in Macacca mulatta (Rhesus monkey) has been reported. 45 In these experiments, significant contamination of transplanted cells with mature lymphocytes as well as other CD34-cells made it difficult to determine the specific contribution of CD34+ cells to lymphopoiesis. More recent studies using retroviruses to infect autologous enriched CD34+ marrow cells from Rhesus monkeys have suggested that CD34+ cells contribute to reconstitution of both lymphopoiesis and myelop~iesis.~~ However, some of these animals had viremias due to contamination of the retroviruses with helper virus, and they also developed lymphomas. This raises the possibility of continued dissemination of virus within animals after transplantation, including those that were not obviously viremic. This makes it more difficult to determine if the marked cells detected originated from donor cells infected in vitro or from donor or residual host cells infected after transplantation. Isolated human CD34+ fetal liver cells injected into fetal thymic grafts in SCID mice can give rise to T lymphocytes, while in vitro the same population of cells can give rise to myeloid CFC and, in fetal bone grafts can give rise to myeloid and B lymphoid cells.4749 Although, these findings argue for the pluripotent potential of such cells, they still do not demonstrate the ability of these cells to sustain lymphohematopoiesis in whole animals.
In the present studies, there were no clonal markers to allow the progeny of individual cells to be distinguished. Therefore, it could not be determined if there were individual CD34+ cells that contributed both to the lymphoid and myeloid lineages. Definitive evidence of the pluripotent nature of cells expressing the CD34 antigen will require assessment of individually marked donor cells. However, the stability of the lymphohematopoietic reconstitution over time in the present experiments supports the hypothesis that pluripotent HSCs are present in CD34+, lymphocyte-depleted marrow cells.
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